Biotech
INVESTOR ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Fortress Biotech, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
INVESTOR ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Fortress Biotech, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm PR Newswire LOS more...
Biotech
CELSION CORPORATION ANNOUNCES $35 MILLION REGISTERED DIRECT OFFERING PRICED AT-THE-MARKET UNDER NASDAQ RULES
LAWRENCEVILLE, NJ, Jan. 22, 2021 (GLOBE NEWSWIRE) — Celsion Corporation (NASDAQ: CLSN) (“Celsion” or the “Company”), today announced it has entered into definitive agreements with institutional investors for the purchase and sale of 25,925,925 shares of more...
Biotech
aTyr Pharma to Present Poster Highlighting Research Approach for Identifying Receptor Targets for Extracellular tRNA Synthetases
Poster to be presented at the 2021 Society for Laboratory Automation and Screening Digital International Conference and Exhibition. Research approach led to the identification of target receptors for two tRNA synthetases and further validates company’s more...
Biotech
Equillium Announces Acceptance of Late-Breaking Abstract for Oral Presentation of Interim Data from EQUATE Study in acute GVHD at the 2021 TCT Meetings Digital Experience
LA JOLLA, Calif., Jan. 22, 2021 (GLOBE NEWSWIRE) — Equillium, Inc. (Nasdaq: EQ) a clinical-stage biotechnology company developing itolizumab to treat severe autoimmune and inflammatory disorders, today announced that interim data from the Phase 1b/2 more...
Biotech
Immutep Quarterly Activities Report
Highlights Encouraging efti data reported from phase IIb AIPAC and phase II TACTI-002 clinical trials TACTI-002 study expanded in lung cancer New phase II trial in head and neck cancer announced EOC Pharma starts new more...
Biotech
Ulcerative Colitis Phase II Study of GSK2831781 Discontinued
Immutep’s Collaboration and Exclusive License with GSK Remains in Place Sydney, AUSTRALIA, Jan. 22, 2021 (GLOBE NEWSWIRE) — Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a biotechnology company developing novel immunotherapy treatments more...
Biotech
ROSEN, TRUSTED INVESTOR COUNSEL, Reminds Fortress Biotech, Inc. Investors of Important January 26 Deadline in Securities Class Action – FBIO
NEW YORK, Jan. 21, 2021 (GLOBE NEWSWIRE) — Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Fortress Biotech, Inc. (NASDAQ: FBIO) between December 11, 2019 and October 9, more...
Biotech
SHAREHOLDER ALERT: WeissLaw LLP Reminds CPAH, CATM, ANCN and GNBF Shareholders About Its Ongoing Investigations
SHAREHOLDER ALERT: WeissLaw LLP Reminds CPAH, CATM, ANCN and GNBF Shareholders About Its Ongoing Investigations PR Newswire NEW YORK , Jan. 21, 2021 /PRNewswire/ — If you own shares in any of the companies listed more...
Biotech
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Reminds Investors of Investigations of INFO, PS, CATM, and ANCN Mergers
WILMINGTON, Del., Jan. 21, 2021 (GLOBE NEWSWIRE) — Rigrodsky Law, P.A. announces that it is investigating: IHS Markit Ltd. (NYSE: INFO ) regarding possible breaches of fiduciary duties and other violations of law related to more...
Biotech
DEADLINE ALERT for FBIO, SPLK, and BSX: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
LOS ANGELES, Jan. 21, 2021 (GLOBE NEWSWIRE) — The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have more...